Choice of Starting Dose for Biopharmaceuticals in First-In-Human Phase I Cancer Clinical Trials
Oncologist - United States
doi 10.1634/theoncologist.2015-0008
Full Text
Open PDFAbstract
Available in full text
Date
May 11, 2015
Authors
Publisher
Alphamed Press